Cancer Research CR  2010 Workshops
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kucherlapati, M. H.
Right arrow Articles by Kucherlapati, R. S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kucherlapati, M. H.
Right arrow Articles by Kucherlapati, R. S.
[Cancer Research 66, 3576-3583, April 1, 2006]
© 2006 American Association for Cancer Research


Cell, Tumor, and Stem Cell Biology

Inactivation of Conditional Rb by Villin-Cre Leads to Aggressive Tumors outside the Gastrointestinal Tract

Melanie H. Kucherlapati1, Andrew A. Nguyen1, Roderick T. Bronson2,3 and Raju S. Kucherlapati1

1 Harvard-Partners Center for Genetics and Genomics and 2 Rodent Histopathology Core, Harvard Medical School; 3 Department of Pathology, Tufts University Schools of Medicine and Veterinary Medicine, Boston, Massachusetts

Requests for reprints: Melanie H. Kucherlapati, Harvard-Partners Center for Genetics and Genomics, Harvard Medical School, 77 Avenue Louis Pasteur, New Research Building 160B, Boston, MA 02115. Phone: 617-525-4438; Fax: 617-525-4435; E-mail: mkucherlapati{at}rics.bwh.harvard.edu.

We have crossed mice carrying the conditional Rbtm2Brn allele with a constitutive Villin-Cre transgenic mouse. The Villin promoter in these animals is highly expressed in adult intestine and kidney proximal tubules and is expressed in the gut and nephros anlagen during embryogenesis. We report here that these mice develop tumors between 12 and 17 months old outside the gastrointestinal (GI) tract. A high penetrance of pituitary tumors and medullar carcinoma of the thyroid is observed with a lower incidence of hyperplasia of pulmonary neuroendocrine cells and aggressive liver, bile duct, stomach, oral cavity tumors, and lipomas. Rb rearrangement due to ectopic Villin promoter activity in neural crest or neural crest stem cells during embryogenesis is most likely responsible for the medullar carcinoma of the thyroid phenotype. The aggressive nature of the medullar carcinoma of the thyroid and its ability to metastasize to unusual sites make the model suitable for the study of tumor progression and mechanism of metastasis. Observed sites of metastasis include the stomach, small intestine, liver, lung, kidney, pancreas, spleen, bone marrow, salivary gland, fat, lymph nodes, and dorsal root ganglion. Because the Villin promoter is highly active throughout the GI and in the nephros anlagen during development, we find that Rb inactivation is not sufficient to initiate tumorigenesis in the GI or kidneys in mice. (Cancer Res 2006; 66(7): 3576-83)




This article has been cited by other articles:


Home page
J Mol EndocrinolHome page
A. Cerrato, V. De Falco, and M. Santoro
Molecular genetics of medullary thyroid carcinoma: the quest for novel therapeutic targets
J. Mol. Endocrinol., October 1, 2009; 43(4): 143 - 155.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
J. Guo, S. Longshore, R. Nair, and B. W. Warner
Retinoblastoma Protein (pRb), but Not p107 or p130, Is Required for Maintenance of Enterocyte Quiescence and Differentiation in Small Intestine
J. Biol. Chem., January 2, 2009; 284(1): 134 - 140.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
M. H. Kucherlapati, K. Yang, K. Fan, M. Kuraguchi, D. Sonkin, A. Rosulek, M. Lipkin, R. T. Bronson, B. J. Aronow, and R. Kucherlapati
Loss of Rb1 in the gastrointestinal tract of Apc1638N mice promotes tumors of the cecum and proximal colon
PNAS, October 7, 2008; 105(40): 15493 - 15498.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
N. A. Mason-Richie, M. J. Mistry, C. A. Gettler, A. Elayyadi, and K. A. Wikenheiser-Brokamp
Retinoblastoma Function Is Essential for Establishing Lung Epithelial Quiescence after Injury
Cancer Res., June 1, 2008; 68(11): 4068 - 4076.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
M. T. Saenz-Robles, J. A. Markovics, J.-L. Chong, R. Opavsky, R. H. Whitehead, G. Leone, and J. M. Pipas
Intestinal Hyperplasia Induced by Simian Virus 40 Large Tumor Antigen Requires E2F2
J. Virol., December 1, 2007; 81(23): 13191 - 13199.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 2006 by the American Association for Cancer Research.